Ct-053-ptsa Free Base
Ct-053-ptsa Free Base Uses, Dosage, Side Effects, Food Interaction and all others data.
Ct-053-ptsa Free Base is under investigation in clinical trial NCT03758287 (Ct-053-ptsa Free Base (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative).
Trade Name | Ct-053-ptsa Free Base |
Generic | Ningetinib |
Ningetinib Other Names | Ct-053 free base, Ct-053-ptsa free base, Ct053ptsa free base |
Type | |
Formula | C31H29FN4O5 |
Weight | Average: 556.594 Monoisotopic: 556.212198213 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Ct-053-ptsa Free Base